 RADNOR, Pa.--BUSINESS WIRE--- MRNS MarinusPharma--Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in Tuberous Sclerosis Complex and Receives FDA Orphan Drug Designation 